Atogepant
ATC Code
N02CD07
Atogepant
Definition
An orally bioavailable calcitonin gene-related peptide (CGRP) receptor antagonist that can be used in the preventive treatment of migraines. Upon oral administration, atogepant targets, binds to and blocks the activity of CGRP receptor, thereby preventing CGRP-mediated signaling. By blocking the CGRP-mediated pathways, atogepant is able to relieve or prevent migraine. CGRP-mediated signaling plays a key role in migraine pathogenesis.
Also known as ATOGEPANT, Qulipta — per NCIT
Also identified as
- ATC N02CD07 per RXNORM
- NCIT NCIT:C167018 per NCIT
- SCTID 2054131000122101 per RXNORM
- UNII 7CRV8RR151 per RXNORM
Indications
| Disease | Relation | Source |
|---|---|---|
| Migraine | may treat | MEDRT · Public domain (U.S. Government work) |